Active, not recruiting
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575
- Conditions
- Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
- Locations
-
- Local Institution - 101 Santa Rosa, California, United States
- Local Institution - 105 Kansas City, Missouri, United States
- Local Institution - 100 Durham, North Carolina, United States
- Local Institution - 106 Dallas, Texas, United States